However, HBx can counteract this by stimulating CREB-mediated activation of miR-3188 and the Notch signaling pathway via ZHX2 inhibition, underlining its significance in HBV-related liver cancer (Zhou et al., 2017). Here, CREB1 is linked to liver cancer.